Long M

No ORCID on file · 7 papers in corpus · active 2012-2026

Study types

  • article 1
  • other 1

Condition tags

  • endometriosis 2
  • adenomyosis 1
2026
Frontiers in cell and developmental biology ·doi:10.3389/fcell.2026.1803566

BackgroundGermline mutations in genes governing DNA repair, cell cycle regulation, and epigenetic modification are now recognized as common etiological factors for both cancer predisposition and reproductive dysfunction. This reveals a prof…

2023
Environmental research ·doi:10.1016/j.envres.2022.114650

While human regulatory risk assessment (RA) still largely relies on animal studies, new approach methodologies (NAMs) based on in vitro, in silico or non-mammalian alternative models are increasingly used to evaluate chemical hazards. Moreo…

2020
Cell cycle (Georgetown, Tex.) ·doi:10.1080/15384101.2020.1831254

Pancreatic cancer (PC) is a leading cause of cancer mortality and is expected to continue increasing incidence. Abnormally expressed microRNAs have been demonstrated tightly correlated with the development and progression of PC. However, th…

article 2020
APL bioengineering ·doi:10.1063/5.0001994

Cyclic myometrial contractions of the non-pregnant uterus induce intra-uterine peristaltic flows, which have important roles in transport of sperm and embryos during early stages of reproduction. Hyperperistalsis in young females may lead t…

2017
AME case reports ·doi:10.21037/acr.2017.09.03

A 48-year-old woman was admitted for pectoralgia and dyspnea. Tomography revealed a giant lung bulla with a mass arose from the bulla wall in the left lower lobes, and left lower lobes pulmonary wedge resection was performed through video-a…

other 2015
International journal of molecular medicine ·doi:10.3892/ijmm.2015.2082

Endometriosis is a prevalent and complex gynecological disease which affects 10% of women of reproductive age. Certain studies have suggested that a substantial number of microRNAs (miRNAs or miRs) are aberrantly or differentially expressed…

2012
BMC cancer ·doi:10.1186/1471-2407-12-161

BackgroundIn premenopausal women, endocrine adjuvant therapy for breast cancer primarily consists of tamoxifen alone or with ovarian suppressive strategies. Toremifene is a chlorinated derivative of tamoxifen, but with a superior risk-benef…